Correlation Between MYR and Aquestive Therapeutics

Specify exactly 2 symbols:
Can any of the company-specific risk be diversified away by investing in both MYR and Aquestive Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining MYR and Aquestive Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between MYR Group and Aquestive Therapeutics, you can compare the effects of market volatilities on MYR and Aquestive Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in MYR with a short position of Aquestive Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of MYR and Aquestive Therapeutics.

Diversification Opportunities for MYR and Aquestive Therapeutics

0.27
  Correlation Coefficient

Modest diversification

The 3 months correlation between MYR and Aquestive is 0.27. Overlapping area represents the amount of risk that can be diversified away by holding MYR Group and Aquestive Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Aquestive Therapeutics and MYR is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on MYR Group are associated (or correlated) with Aquestive Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Aquestive Therapeutics has no effect on the direction of MYR i.e., MYR and Aquestive Therapeutics go up and down completely randomly.

Pair Corralation between MYR and Aquestive Therapeutics

Given the investment horizon of 90 days MYR is expected to generate 5.33 times less return on investment than Aquestive Therapeutics. But when comparing it to its historical volatility, MYR Group is 2.0 times less risky than Aquestive Therapeutics. It trades about 0.03 of its potential returns per unit of risk. Aquestive Therapeutics is currently generating about 0.07 of returns per unit of risk over similar time horizon. If you would invest  196.00  in Aquestive Therapeutics on August 26, 2024 and sell it today you would earn a total of  260.00  from holding Aquestive Therapeutics or generate 132.65% return on investment over 90 days.
Time Period3 Months [change]
DirectionMoves Together 
StrengthVery Weak
Accuracy100.0%
ValuesDaily Returns

MYR Group  vs.  Aquestive Therapeutics

 Performance 
       Timeline  
MYR Group 

Risk-Adjusted Performance

16 of 100

 
Weak
 
Strong
Solid
Compared to the overall equity markets, risk-adjusted returns on investments in MYR Group are ranked lower than 16 (%) of all global equities and portfolios over the last 90 days. Despite nearly weak basic indicators, MYR reported solid returns over the last few months and may actually be approaching a breakup point.
Aquestive Therapeutics 

Risk-Adjusted Performance

2 of 100

 
Weak
 
Strong
Weak
Compared to the overall equity markets, risk-adjusted returns on investments in Aquestive Therapeutics are ranked lower than 2 (%) of all global equities and portfolios over the last 90 days. In spite of comparatively weak basic indicators, Aquestive Therapeutics may actually be approaching a critical reversion point that can send shares even higher in December 2024.

MYR and Aquestive Therapeutics Volatility Contrast

   Predicted Return Density   
       Returns  

Pair Trading with MYR and Aquestive Therapeutics

The main advantage of trading using opposite MYR and Aquestive Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if MYR position performs unexpectedly, Aquestive Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Aquestive Therapeutics will offset losses from the drop in Aquestive Therapeutics' long position.
The idea behind MYR Group and Aquestive Therapeutics pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.
Check out your portfolio center.
Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Optimizer module to use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio .

Other Complementary Tools

Idea Analyzer
Analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas
Portfolio Manager
State of the art Portfolio Manager to monitor and improve performance of your invested capital
Economic Indicators
Top statistical indicators that provide insights into how an economy is performing
Price Ceiling Movement
Calculate and plot Price Ceiling Movement for different equity instruments
Stock Tickers
Use high-impact, comprehensive, and customizable stock tickers that can be easily integrated to any websites